Study S000083

WeDosify Real-World Evidence: Evaluating a Clinical Decision Support and Patient Engagement Tool for Personalized Semaglutide Dosing in Adults With Overweight or Obesity in the United States

ClinicalTrials.gov record

Registration

Registration: NCT07216651
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 20
Start: 2025-09-23
Primary completion: 2026-02-27
Lead sponsor: Closed Loop Medicine
Conditions: Obesity & Overweight
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Percentage of participants who persisted on semaglutide treatment over the study period [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.